Mathias holds a master’s in engineering in Molecular Biotechnology from Uppsala University and Ph.D. in molecular biology from Karolinska Institutet. He is a co-founder of the cord blood bank Cellaviva, established in 2014, a company that has evolved to NextCell Pharma AB which is developing stem cell-based therapies for autoimmune diseases. Currently, NextCell has two ongoing clinical trials in type-1 diabetes.
The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.